BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

655 related articles for article (PubMed ID: 23830467)

  • 1. IORT with electrons as boost strategy during breast conserving therapy in limited stage breast cancer: long term results of an ISIORT pooled analysis.
    Fastner G; Sedlmayer F; Merz F; Deutschmann H; Reitsamer R; Menzel C; Stierle C; Farmini A; Fischer T; Ciabattoni A; Mirri A; Hager E; Reinartz G; Lemanski C; Orecchia R; Valentini V
    Radiother Oncol; 2013 Aug; 108(2):279-86. PubMed ID: 23830467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
    Fastner G; Reitsamer R; Ziegler I; Zehentmayr F; Fussl C; Kopp P; Peintinger F; Greil R; Fischer T; Deutschmann H; Sedlmayer F
    Int J Cancer; 2015 Mar; 136(5):1193-201. PubMed ID: 24995409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial.
    Polgár C; Fodor J; Major T; Sulyok Z; Kásler M
    Radiother Oncol; 2013 Aug; 108(2):197-202. PubMed ID: 23742961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiotherapy boost dose-escalation for invasive breast cancer after breast-conserving surgery: 2093 patients treated with a prospective margin-directed policy.
    Livi L; Meattini I; Franceschini D; Saieva C; Meacci F; Marrazzo L; Gerlain E; Desideri I; Scotti V; Nori J; Sanchez LJ; Orzalesi L; Bonomo P; Greto D; Bianchi S; Biti G
    Radiother Oncol; 2013 Aug; 108(2):273-8. PubMed ID: 23490271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
    Sedlmayer F; Zehentmayr F; Fastner G
    Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
    Reitsamer R; Peintinger F; Kopp M; Menzel C; Kogelnik HD; Sedlmayer F
    Strahlenther Onkol; 2004 Jan; 180(1):38-44. PubMed ID: 14704843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IOERT versus external beam electrons for boost radiotherapy in stage I/II breast cancer: 10-year results of a phase III randomized study.
    Ciabattoni A; Gregucci F; Fastner G; Cavuto S; Spera A; Drago S; Ziegler I; Mirri MA; Consorti R; Sedlmayer F
    Breast Cancer Res; 2021 Apr; 23(1):46. PubMed ID: 33849606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated partial breast irradiation with interstitial brachytherapy as second conservative treatment for ipsilateral breast tumour recurrence: multicentric study of the GEC-ESTRO Breast Cancer Working Group.
    Hannoun-Levi JM; Resch A; Gal J; Kauer-Dorner D; Strnad V; Niehoff P; Loessl K; Kovács G; Van Limbergen E; Polgár C;
    Radiother Oncol; 2013 Aug; 108(2):226-31. PubMed ID: 23647758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intraoperative radiation therapy: is it a standard now?
    Orecchia R; Leonardo MC
    Breast; 2011 Oct; 20 Suppl 3():S111-5. PubMed ID: 22015276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local therapy for breast cancer in malignant lymphoma survivors.
    Intra M; Mattar D; Sangalli C; Rotmensz N; Viale G; Galimberti V; Luini A; Veronesi P; Colleoni M; Zurrida S; Orecchia R; Veronesi U
    Breast; 2011 Oct; 20 Suppl 3():S99-103. PubMed ID: 22015303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ESTRO IORT Task Force/ACROP recommendations for intraoperative radiation therapy with electrons (IOERT) in breast cancer.
    Fastner G; Gaisberger C; Kaiser J; Scherer P; Ciabattoni A; Petoukhova A; Sperk E; Poortmans P; Calvo FA; Sedlmayer F; Leonardi MC
    Radiother Oncol; 2020 Aug; 149():150-157. PubMed ID: 32413529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-year results of pulsed dose rate brachytherapy applied as a boost after breast-conserving therapy in patients at high risk for local recurrence from breast cancer.
    Harms W; Krempien R; Hensley FW; Berns C; Fritz P; Wannenmacher M
    Strahlenther Onkol; 2002 Nov; 178(11):607-14. PubMed ID: 12426671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electron and high-dose-rate brachytherapy boost in the conservative treatment of stage I-II breast cancer first results of the randomized Budapest boost trial.
    Polgár C; Fodor J; Orosz Z; Major T; Takácsi-Nagy Z; Mangel LC; Sulyok Z; Somogyi A; Kásler M; Németh G
    Strahlenther Onkol; 2002 Nov; 178(11):615-23. PubMed ID: 12426672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
    Bantema-Joppe EJ; Vredeveld EJ; de Bock GH; Busz DM; Woltman-van Iersel M; Dolsma WV; van der Laan HP; Langendijk JA; Maduro JH
    Radiother Oncol; 2013 Aug; 108(2):269-72. PubMed ID: 24055289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I/II trial of intraoperative breast radiotherapy in an Asian population: 5-year results of local control and cosmetic outcome.
    Kawamura M; Itoh Y; Sawaki M; Kikumori T; Tsunoda N; Kamomae T; Kubota S; Okada T; Nakahara R; Ito J; Hayashi H; Naganawa S
    Radiat Oncol; 2015 Jul; 10():150. PubMed ID: 26205241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncological outcome, postoperative complications, and mammographic changes after intraoperative radiotherapy with electrons (IOERT) as a boost in a large single-institution cohort of breast cancer patients.
    Machiels M; Weytjens R; Erven K; Westerhoff JM; Amrouch S; Bosiers J; Verkinderen L; Hauspy J; van Dam P; Stevens P; Bernaerts A; Strijbos M; Meijnders P; Dirix P; Verellen D; Van Laere S; Vermeulen PB; Billiet C
    Breast J; 2020 Oct; 26(10):1937-1945. PubMed ID: 32779870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term results with breast-conserving therapy for patients with early stage breast carcinoma in a community hospital setting.
    Kini VR; White JR; Horwitz EM; Dmuchowski CF; Martinez AA; Vicini FA
    Cancer; 1998 Jan; 82(1):127-33. PubMed ID: 9428488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraoperative radiotherapy given as a boost for early breast cancer: long-term clinical and cosmetic results.
    Lemanski C; Azria D; Thezenas S; Gutowski M; Saint-Aubert B; Rouanet P; Fenoglietto P; Ailleres N; Dubois JB
    Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1410-5. PubMed ID: 16442241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose-rate brachytherapy boost effect on local tumor control in young women with breast cancer.
    Guinot JL; Baixauli-Perez C; Soler P; Tortajada MI; Moreno A; Santos MA; Mut A; Gozalbo F; Arribas L
    Int J Radiat Oncol Biol Phys; 2015 Jan; 91(1):165-71. PubMed ID: 25446608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery and intraoperative electron radiotherapy in recurrent or metastatic oligotopic extrapelvic cancer: long-term outcome.
    Calvo FA; González ME; González-San Segundo C; González-Bayón L; Lozano MA; Santos-Miranda JA; Alvarez E; García-Sabrido JL
    Eur J Surg Oncol; 2012 Oct; 38(10):955-61. PubMed ID: 22819147
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.